Aesther Healthcare Acquisition Corp.
Status: Deal Closed
U=S+W/2
W=S@11.50
| IPO Proceeds, $M | $105.00M |
|---|---|
| IPO Date | Sep 15, 2021 |
| CEO | Surendra Ajjarapu |
| Left Lead | EF Hutton |
| IPO Cash in Trust | 102.0% |
| SPAC Tenor | 12 + 3 + 3 |
| IPO Sector |
Healthcare
Pharmaceutical and medical devices |
| IPO Geography | Global |
| Target Company | Ocean Biomedical, Inc. |
| Deal Announced | Aug 31, 2022 |
| Deal Size, $M | $274.88M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings | www.sec.gov |
| Approval Vote | Feb 3, 2023 |
| Amendment Vote | TBD |
| Closing Date | Feb 15, 2023 |
Formerly AEHA
OCEA
OCEAW
| Price | $0.73 |
|---|---|
| Last closing price | $0.72 |
| H/L, today | $0.68 / $0.73 |
| H/L, 52-week | $1.60 / $26.60 |
| Volume, today | 24,972 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Aesther Healthcare Acquisition Corp.:
- Structure and cap table
- 6 directors & officers
- 43 filings and events
- 3 underwriters
- 2 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Surendra Ajjarapu | 50 | Chairman, CEO and Director |
| Howard A. Doss | 67 | CFO and Secretary |
| Michael L. Peterson | 59 | Director |
| Venkatesh Srinivasan | 54 | Director |
| Donald G. Fell | 74 | Director |
| Siva Saravanan | 46 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| EF Hutton | BR | 9,945,000 | units |
| B. Riley FBR | 50,000 | ||
| Joseph Gunnar | 5,000 | ||
| 10,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.00 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.